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Background: Opioid abuse has been an increasing problem since the 1990s. With over 47,000 
opioid related deaths recorded in 2017 alone, concerns have been raised regarding the dangers of 
introducing opioids perioperatively to patients undergoing major surgeries. 
Objectives: The present study proposes to examine the frequency, amount, and trends in post-
operative opioid consumption in patients undergoing orthopedic surgical procedures.  
Study Design: This was a randomized, retrospective questionnaire-based study.
Setting: Patients who underwent any type of orthopedic surgery at the University of Pennsylvania 
Presbyterian Hospital from 1/1/2018 to 3/12/2019 were randomly selected and called during the 
summer of 2019.
Methods: In this retrospective questionnaire-based study, 828 patients were called by telephone in 
the summer of 2019. These patients were asked a variety of questions involving opioid consumption 
behavior post-surgery. The study ended after receiving responses from 200 patients.
Results: Nineteen (9.5%) patients reported positively for experiencing euphoria while taking opioids 
post-surgery. Of the 200 patients contacted, 6 patients (3%) reported switching to marijuana instead 
of opioids. Thirty-eight (19%) patients preferred to take no opioids at all post-surgery, and one 
patient was found to have given their prescription to a family member or friend. Twenty-one patients 
(10.5%) were found to have been taking opioids for non-severe pain. Blacks and whites were the 
most common racial demographics, making up 84 and 109 of the totals, respectively. The odds ratios 
for all of the predictors showed that the relative risk for opioid misuse was higher for black patients 
than white patients (OR = 3.034). There was no relationship between the intra- and post-operative 
opioid administration and long-term opioid misuse. 
Limitations: Patients are self-selected and had the option to opt out of the study when contacted. 
Some patients may not have been available to answer the phone when our study was being conducted. 
This study was only conducted for orthopedic patients and for patients who received surgery at the 
University of Pennsylvania Presbyterian Hospital, thus affecting the demographics for our research. 
Conclusions: Prescription opioid misuse is more common among the black population. The total 
opioid consumption is frequently lower than the quantity prescribed. Patients frequently use opioids 
even though they feel that pain is insufficient to deserve such an intervention. Euphoria is experienced 
by a significant number of patients taking prescription opioids Often patients do not take any opioids, 
although they had prescriptions.
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Opioid abuse has been rapidly increasing since the early 1990s (1). Prior to the 1990s, opioid painkillers were primarily prescribed 
to cancer patients (1). However, in 1991 pharmaceutical 
companies began to downplay the long-term negative 
consequences of opioids. This led to a sharp increase 
in opioid prescriptions for noncancer related pain (1). 
This first wave of the opioid epidemic was followed by a 
Pain Physician 2021; 24:E231-E237 • ISSN 2150-1149
Pain Physician: March/April 2021 24:E231-E237
E232  www.painphysicianjournal.com
second wave in 2010, where heroin became a cheaper 
and easier to obtain alternative for opioids (2). In 2013, 
use of synthetic opioids began to increase as well, one 
of which being the drug fentanyl, a very common 
anesthesia medication given to a majority of patients 
undergoing surgery (2). Deaths from opioid abuse 
have become increasingly common among Americans. 
In 2017, over 47,000 deaths were recorded due to 
prescription and nonprescription opioid overdose, and 
deaths are projected to reach nearly 82,000 by 2025 (3). 
The opioid epidemic has also created a large economic 
burden for the country, as increased healthcare and 
substance abuse treatment has cost the United States 
upwards of $78 billion a year (4). 
With the opioid epidemic becoming a major public 
health concern, studies have been conducted to de-
termine the likely contributing factors. Concerns have 
been raised about the dangers of introducing opioids 
perioperatively to an opioid naive patient. One study 
in 2016 found that male and elderly patients (over 50 
years of age) with histories of substance abuse had 
a greater risk of becoming opioid dependent post-
surgery where opioids were introduced (5). Another 
study concluded that a very small proportion of women 
become opioid dependent following cesarean delivery 
(6). Studies have also been conducted to determine 
alternatives to opioid administration in an attempt to 
reduce the amount of prescription painkillers given to 
patients. A study in 2016 concluded that the adminis-
tration of preoperative gabapentin reduced the total 
opioid consumption 24 hours following surgery (7). 
However, many of these studies fall short in pre-
dicting the patient factors that are likely to contribute 
to opioid abuse. Furthermore, much of the literature 
currently published relies on the amount of prescrip-
tions filled by the patient as the opioid abuse indicator, 
giving no evidence of whether the patient was actually 
taking the medication and to what degree. The cur-
rent study aims at directly determining the extent to 
which patients consumed their postoperative opioid 
prescriptions. As evidence suggests, even one tablet 
of a particular opioid may lead to continued use of 
opioids. In this study, we planned to examine whether 
the perioperative introduction of opioids has any effect 
on the patients’ immediate, intermediate, or long-term 
postoperative seeking of opioids. 
Methods
After obtaining the Institutional Review Board’s 
approval, patient and procedural data from 1/1/2018 
to 3/12/2019 of all patients undergoing surgical pro-
cedures was obtained from the billing office. Patients 
who underwent any type of orthopedic surgery at 
the University of Pennsylvania Presbyterian Hospital 
were randomly selected and called over the phone for 
participation in our questionnaire-based study. Any 
children under the age of 18 were excluded from the 
sample. A total of 828 patients were called during the 
hours of 9:00 AM to 5:00 PM and the study was stopped 
after obtaining a total of 200 responses. The types of 
procedures for each patient were categorized into one 
of 19 major classifications. 
Patients who answered the phone were questioned 
for approximately 10 to 15 minutes. Verbal consent 
was obtained from each of the patients participating 
in the study prior to any questions being asked. The 
questionnaire form was filled in real time. Preliminary 
demographics, intraoperative opioid administration, 
and postoperative opioid prescriptions were extracted 
from the electronic medical records. The questions 
included opioid consumption patterns during the 
first week post-surgery and up to 6 months following 
surgery. Patients were also asked about any eupho-
ria they experienced under the influence of opioids, 
whether they took opioids for nonsevere or no pain, 
and whether the patient gave their opioid supplies to 
any friends or family members. Furthermore, any other 
pain management methods employed by the patient, 
such as marijuana consumption, were noted and re-
corded. This study relied on the patient to remember 
opioid consumption behavior during the time period 
up to 6 months following surgery. 
All data regarding opioid prescriptions and the 
patient’s opioid consumption pattern (pill count) 
were converted to the respective Morphine Milligram 
Equivalent (MME) for comparison purposes. Conversion 
factors for intravenous and prescription opioids were 
taken from the center for Medicare and Medicaid ser-
vices website. For patient prescriptions, the maximum 
amount prescribed was used when calculating average 
MME/day. 
All data analysis was completed using IBM SPSS 
Statistics (Version 25.0. Armonk, NY) for Macintosh. 
Means and standard deviations were calculated 
for prescribed opioid MME/day as well as consumed 
MME/day per procedure (Fig. 1). Any procedures with 
less than 4 patients were excluded from the summary 
boxplot. All data were analyzed using binary logistic 
regressions with a P value of 0.05 being considered as 
significant in these comparisons. Statistical analysis was 
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done for different cohorts of demographics as well as 
perioperative indicators to determine whether opioid 
misuse was occurring (Table 1).
Results
Of the 828 patients called for this study, a total 
of 200 responses were recorded. These 200 responses 
were then grouped into one of 19 procedural catego-
ries. Table 2 summarizes all of the demographics for 
the 200 patients screened. All patients were grouped 
by gender, ethnicity, age range, and body mass index 
(BMI) range. Each of the patients were grouped into 4 
different racial categories. Blacks and whites were the 
most common racial demographics, making up 42% 
and 54.5% of the totals respectively. Each of the pa-
tients contacted were also asked of their education lev-
els. Patient education levels were grouped into one of 
8 different categories and reported in Table 2 as well. 
Averages and standard deviations for patient 
prescriptions were also calculated for each of the pro-
cedural categories. These were then compared against 
the averages and standard deviations for the patient 
95% C.I. for Odds Ratio





Gender .649 .549 1.400 1 .237 1.914 .653 5.608
Age at Time of Surgery .000 .022 .000 1 .989 1.000 .957 1.044
Race 1.110 .534 4.318 1 .038 3.034 1.065 8.640
Euphoric .592 .786 .566 1 .451 1.807 .387 8.438
Intraoperative Opioid MME .005 .018 .086 1 .770 1.005 .971 1.041
Prescription MME Day .013 .009 1.900 1 .168 1.013 .995 1.032
Constant -3.987 1.433 7.736 1 .005 .019
Table 1. Summary statistics.
a Variable(s) entered on Step 1: Gender, AgeatTimeofSurgery, Race, Euphoric, IntraopOpioidMME, PrescriptionMMEDay
Fig. 1. Mean and standard deviations for prescription and consumption opioid MME/day for each procedure.
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consumption pattern per day (MME/day) for each 
procedure. Fig. 1 summarizes these results in a multi 
boxplot format, however those surgeries with less than 
4 patients were excluded from the diagram. As seen 
from graph, the average patient consumption pattern 
for all of the procedural categories shown was as much 
or less than the prescribed MME/day. 
We also screened our patients to determine 
whether opioids were being consumed for pain that 
was not reported as severe. Twenty-one patients out 
of the 200 total (10.5%) were found to have been 
taking opioids for nonsevere pain. For analytical pur-
poses, we characterized any behavior involving the 
consumption of opioids for non-severe or no pain as 
opioid misuse.
Statistical analysis was used to determine which 
predictors may affect the patient’s likeliness to misuse 
opioids. A binary logistic regression was done for differ-
ent predictors that may influence opioid misuse. Each 
of the predictors that were included in the model are 
seen in Table 1. Only patients who identified as black 
or white were used in the model, due to low responses 
from other ethnicities. The intraoperative opioid MME 
administered during surgery as well as the prescription 
MME/day for each of the patients were used as factors 
to predict opioid misuse as well. Lastly, patients were 
screened to determine whether they reported any feel-
ings of euphoria while consuming the prescribed opi-
oids, of which 19 patients reported positively (9.5%). 
This was also used as a predictor in our model.
Although the model itself was not considered 
significant (P = 0.140), it is worth noting that the race 
predictor did report a significant finding (P = 0.038). 
The odds ratios for all of the predictors are also re-
ported in Table 1. As shown, the relative risk for opi-
oid misuse was higher for black patients than white 
patients (OR = 3.034, 95% Confidence Interval, 1.065 
to 8.640).
Other forms of pain management such as mari-
juana were found to be effective for patients post-
surgery, with 6 patients out of the 200 reporting to 
have switched to marijuana instead of opioids (3%). 
Although it is uncertain in what form these patients 
used marijuana (whether medicinally or recreationally), 
all patients who reported to have been self-prescribing 
marijuana instead of opioids experienced significant 
pain relief (self-reported by patients). Furthermore, 38 
patients preferred to take no opioids at all post-surgery 
(19%), and only one patient was found to have given 









Hispanic or Latino 4
Age Range
< 20 1
21 – 30 17
31 – 40 40
41 – 50 36
51 – 60 58
61 – 70 48
BMI Range
< 18.5 1
18.5 – 24.9 38




No formal education credential 8
High school diploma or equivalent 51
Some college, no degree 36




Doctoral or professional degree 21




















Table 2. Demographics of  study.
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discussion
As defined by the Federation of State Medical 
Boards, opioid misuse “encompasses all uses of a pre-
scription medication other than those that are directed 
by a clinician.” This may include taking a dose when it 
is not necessary, taking a larger dose than instructed, or 
taking the dose in a different manner than prescribed, 
such as through injection or snorting (8). This is distinct 
from Opioid Use Disorder (OUD), which is also referred 
to as opioid addiction. OUD or opioid addiction is 
characterized by a powerful, compulsive urge to use 
opioids when not medically required, which may result 
in significant impairment or distress (9,10). Given these 
definitions, for the purposes of our study, any patient 
reported to have consumed opioids for non-severe pain 
was characterized as misusing opioids.
Our study suggests that prescription opioid mis-
use is more common among the black population. 
Furthermore, comparison between prescription opioid 
amounts and patient consumption patterns reveal that 
the total opioid consumption is frequently lower than 
the quantity prescribed. Results from our question-
naire suggest that patients frequently use opioids 
even though they feel that their pain is insufficient to 
deserve such an intervention (10.5%). Euphoria is also 
experienced by a significant number of patients taking 
prescription opioids (9.5%). It is also important to note 
that some patients recourse to drugs such as marijuana 
to relieve pain (3%). Furthermore, patients rarely of-
fer their personal prescription opioids to friends and 
family members (0.5%) and often times, patients opt to 
not take any opioids, although they had prescriptions 
(19%).
Although, in terms of percentages these above 
observations are small, it is important to extrapolate 
these figures to total national opioid prescriptions and 
the public health hazard posed by such conduct. In ad-
dition, one should bear in mind that patients may be 
hesitant to disclose such aspects of opioid use/misuse, 
even in a confidential research setting and as a result 
the real magnitude of problem at national level is likely 
to be significantly more than revealed in our study.  
As mentioned in the results, Table 1 summarizes 
the statistics from the binary logistic regression con-
ducted to predict opioid misuse. While the model was 
not significant, it is important to note that the race 
predictor used in the model did result in a significant 
finding, indicating that blacks are more likely to misuse 
opioids than whites. Although this cannot be consid-
ered a significant finding due the model’s overall insig-
nificance, its implications could be useful for guiding 
future opioid prescription behavior. Furthermore, it is 
worthy to note that these findings are in contrast to 
those concluded from a study conducted by Unick et al 
(11) who found that whites, women, and middle-aged 
individuals had the largest increase in prescription 
related opioid overdoses since 2007. While our study 
did not aim at predicting opioid related overdoses, we 
believe that opioid misuse is a major contributor to 
opioid overdose.  
For all types of surgeries, the average prescription 
was higher than the average MME consumed per day. 
These results support those findings found by Makary 
et al (12) which conclude that over prescription is a 
major contributor to the opioid epidemic. 
Our study indicates that patients undergoing 
orthopedic surgeries often use opioids even though 
they feel that pain is insufficient to deserve such an 
approach. Similar findings were reported by Shah et 
al (13). Their retrospective database study included a 
large number of managed care plans and was repre-
sentative of the U.S. commercially insured population. 
They noticed that, in cancer-free adults who received a 
prescription for opioid pain relievers, the likelihood of 
chronic opioid use increased with each additional day 
of medication supplied starting with the third day, with 
the sharpest increases in chronic opioid use observed 
after the fifth and thirty-first day on therapy. Other fac-
tors that contributed to chronic use included a second 
prescription or refill, 700 morphine milligram equiva-
lents cumulative dose, and an initial 10- or 30-day 
supply. Similarly, Harbaugh et al (14) found persistent 
opioid use in 4.8% of children who filled a postopera-
tive opioid prescription.
Research suggests that cannabis should not neces-
sarily be considered an optimal choice as a drug for pain 
management (15). However, the general absence of CBD 
in what is used “medically,” and the methodological 
challenges in conducting research are some of the pro-
posed challenges in making such recommendations (16).
A study found that the prevalence rate for bor-
rowing someone’s prescription medication was 5% 
to 51.9% and for lending prescription medication 
to someone else was 6% to 22.9%. Sharing primarily 
occurs between family members, friends, and acquain-
tances (17). Both recreational and nonrecreational 
sharing is seen. In another study (18), a total of 20.7% 
(weighted percentage) reported ever having shared 
opioid medications with another person. This is primar-
ily done to help the other person manage pain. 
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Euphoria is especially common with fentanyl, 
fentanyl analogs, and other new synthetic opioids 
(19). Currently, fentanyl is one of the most commonly 
abused/misused opioid drugs in the USA (20). In our 
study, 19 patients (9.5%) reported in the affirmative on 
the question of experiencing euphoria.
Thirty-eight patients (19%) in our study preferred 
to take no opioids at all post-surgery, even though they 
had prescriptions. This indicates that we fail to recog-
nize the patients who would take/require/benefit from 
such a prescription. While it is likely that many patients 
may have preferred to tolerate pain for the fear of ad-
diction after appropriate consumption, there could be 
other reasons why patients may have preferred not to 
take opioids. One of which is opioid induced constipa-
tion (OIC). OIC is one of the most common side effects 
of opioid consumption and is experienced by more 
than 40% of patients taking opioids for chronic non-
cancer pain (21). As the amount of prescription opioids 
increase, it is likely that more patients are dissuaded 
from using such opioids out of fear from such gastroin-
testinal symptoms (22). Along with OIC, urinary reten-
tion is also a major factor that may dissuade patients 
from consuming prescription opioids (23).
There were also a few limitations to the scope of 
our study. Firstly, patients are self-selected and had 
the option to opt out of the study when contacted. 
Furthermore, some patients may not have been avail-
able to answer the phone when our study was being 
conducted. This is the reason for our 24.2% turnover 
rate when considering the patients screened and those 
called (200 out of 826). This resulted in our study not 
being entirely random, since particular demographics 
may be more likely to answer and opt in to the study. 
Secondly, this study was only conducted for orthopedic 
patients and for patients who received surgery at the 
University of Pennsylvania Presbyterian Hospital, thus 
further affecting the demographics for our research. 
Future directions include incorporating more pa-
tients from other types of surgeries as well as consid-
ering a greater number of patients for our predictive 
model. Screening patients in person rather than over 
the phone may also help provide more accurate data 
as well as a greater total number of patents. Perhaps 
talking with patients prior to surgery could also help 
mitigate possible opioid misuse or over prescription. 
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